Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 15JANSSEN PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 8785500

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-2502

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-05

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 9592207

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-2502

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-03-20

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11173134

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3536

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-10

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11883526

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3812

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-02-18

blank

05

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11883526

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3813

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-02-18

blank

06

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11311500

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3034

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-10

blank

07

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11311500

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3036

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-10

blank

08

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11311500

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3035

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-10

blank

09

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11173134

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3257

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-09-10

blank

10

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ESKETAMINE HYDROCHLORIDE

US Patent Number : 11446260

Drug Substance Claim :

Drug Product Claim :

Application Number : 211243

Patent Use Code : U-3444

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank